Code of Federal Regulations · Subpart
Subpart H — Payment For End-stage Renal Disease (esrd) Services
42 C.F.R. pt. 413, subpt. H
- § 413.170 Scope
- § 413.171 Definitions
- § 413.172 Principles Of Prospective Payment
- § 413.174 Prospective Rates For Hospital-based And Independent Esrd Facilities
- § 413.176 Amount Of Payments
- § 413.177 Quality Incentive Program Payment
- § 413.178 Esrd Quality Incentive Program
- § 413.180 Procedures For Requesting Exceptions To Payment Rates
- § 413.182 Criteria For Approval Of Exception Requests
- § 413.184 Payment Exception: Pediatric Patient Mix
- § 413.186 Payment Exception: Self-dialysis Training Costs In Pediatric Facilities
- § 413.194 Appeals
- § 413.195 Limitation On Review
- § 413.196 Notification Of Changes In Rate-setting Methodologies And Payment Rates
- § 413.198 Recordkeeping And Cost Reporting Requirements For Outpatient Maintenance Dialysis
- § 413.200 [reserved]
- § 413.202 Organ Procurement Organization (opo) Cost For Kidneys Sent To Foreign Countries Or Transplanted In Patients Other Than Medicare Beneficiaries
- § 413.203 Transplant Center Costs For Organs Sent To Foreign Countries Or Transplanted In Patients Other Than Medicare Beneficiaries
- § 413.210 Conditions For Payment Under The End-stage Renal Disease (esrd) Prospective Payment System
- § 413.215 Basis Of Payment
- § 413.217 Items And Services Included In The Esrd Prospective Payment System
- § 413.220 Methodology For Calculating The Per-treatment Base Rate Under The Esrd Prospective Payment System Effective January 1, 2011
- § 413.230 Determining The Per Treatment Payment Amount
- § 413.231 Adjustment For Wages
- § 413.232 Low-volume Adjustment
- § 413.233 Additional Facility-level Adjustments
- § 413.234 Drug Designation Process
- § 413.235 Patient-level Adjustments
- § 413.236 Transitional Add-on Payment Adjustment For New And Innovative Equipment And Supplies
- § 413.237 Outliers
- § 413.239 Transition Period
- § 413.241 Pharmacy Arrangements